Inotek Snags $9.3M


Inotek Pharmaceuticals of Lexington, MA, has bumped its latest financing up to $23.6 million, with nearly $10 million in new funding, according to an SEC filing. The drug developer raised $14.3 million last summer from investors such as Devon Park Bioventures, Care Capital, Rho Ventures, MedImmune Ventures, and Bio*One Capital.

By posting a comment, you agree to our terms and conditions.